Corpus ID: 39356527

[Contribution to the stability of tropicamide solutions (author's transl)].

@article{PohloudekFabini1982ContributionTT,
  title={[Contribution to the stability of tropicamide solutions (author's transl)].},
  author={R. Pohloudek-Fabini and E. Mart{\'i}n and V. Gallasch},
  journal={Die Pharmazie},
  year={1982},
  volume={37 3},
  pages={
          184-7
        }
}
The course of the degradation of tropicamide solutions was elucidated. Thus, inter alia, intramolecular elimination of water leads to a compound comparable to apoatropine that the authors designated by atropicamide. Furthermore, methods are described that permit (after thin-layer chromatographic repartition) to detect and to determine quantitatively the active principle in the presence of its degradation products. Tropicamide is stable in aqueous solution; eye-drops prepared from such a… Expand
Extractive Spectrophotometric Method for the Determination of
Tropicamide (TPC), [Scheme 1] (R,S)-N-ethyl-3hydroxy-2-phenyl-N-(pyrid-4-ylmethyl) propionamide, is a tropic acid derivative endowed with short duration of antimuscarinic activity and available inExpand
Spectrophotometric Determination of Tropicamide in Bulk and Pharmaceutical Formulations
A simple and sensitive extractive spectrophotometric method is described for determination of tropicamide. The method is based on the reaction of tropicamide and bromocresol green. The ion-pairedExpand
Extractive Spectrophotometric Method for the Determination of Tropicamide
TLDR
Two simple, rapid, and extractive spectrophotometric methods were developed for the determination of tropicamide (TPC) and have been applied successfully for the analysis of TPC in pure and in its eye drops. Expand
Extemporaneously Used Drug Formulations for Ocular Emergencies
TLDR
This chapter covers benefits of extemporaneously compounded formulations, regulatory requirements of compounding pharmacy, components of ophthalmic formulations, requirements for active/auxiliary ingredients, sterilization procedures, packaging, cost effectiveness, related risk factors and stability of compounded formulations etc. Expand